View in EDS HTML Full Text PDF Full Text

Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing.

Saved in:
Bibliographic Details
Title: Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing.
Authors: Homšek Ilić, Ana1 (AUTHOR), Jovanović, Marija1 (AUTHOR), Marković, Srđan2,3 (AUTHOR), Vezmar Kovačević, Sandra1 (AUTHOR), Knežević Ivanovski, Tamara2 (AUTHOR), Kralj, Đorđe2 (AUTHOR), Svorcan, Petar2,3 (AUTHOR), Vučićević, Katarina1 (AUTHOR) katarina.vucicevic@pharmacy.bg.ac.rs
Source: PLoS ONE. 7/24/2026, Vol. 21 Issue 7, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0352967